diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/2072-0351-5685diaendo-5685Research ArticleСтатьиArticlesБазальная инсулинотерапия у пациентов с сахарным диабетом 2 типа с неудовлетворительным контролем гликемиина пероральной сахароснижающей терапии: результаты прямого сравнительного исследования аналогов инсулина Лантус и ЛевемирBasal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and LevemirЗалевскаяАлсу ГафуровнаZalevskayaAlsu Gafurovna-ВербоваяНелли ИльиничнаVerbovayaNelli Il'inichna-РодионоваТатьяна ИгоревнаRodionovaTatiana Igorevna-ВикуловаОльга КонстантиновнаVikulovaOlga Konstantinovnanephro@endocrincentr.ruШестаковаМарина ВладимировнаShestakovaMarina Vladimirovna-ГОУ ВПО Санкт-Петербургский медицинский университет им. И.П. Павлова, городская многопрофильная больница № 2, Санкт-ПетербургI.P. Pavlov Sankt-Peterburg Medical University, City multi-field hospital № 2, Sankt-PeterburgООО «Центр Диабет», СамараSamara State Medical University, Diabet Centre, SamaraГОУ ВПО Саратовский государственный медицинский университет им. В.И. Разумовского, СаратовV.I. Razumovsky State Medical University, SaratovФГУ Эндокринологический научный центр, МоскваEndocrinology Research Centre, Moscow201015062010132№2 (2010)106112Copyright © Залевская А.Г., Вербовая Н.И., Родионова Т.И., Викулова О.К., Шестакова М.В., 20102010Залевская А.Г., Вербовая Н.И., Родионова Т.И., Викулова О.К., Шестакова М.В.Zalevskaya A.G., Verbovaya N.I., Rodionova T.I., Vikulova O.K., Shestakova M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/5685сахарный диабет 2 типабазальная инсулинотерапияаналоги инсулина человека гларгин и детемирпрямое сравни- тельное исследованиеpe 2 diabetes mellitusbasal insulin therapyinsulin analogs glargin and detemirdirect comparative studyReferencesKoro C.E., Bowlin S.J., Bourgeois N., Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report // Diabetes Care. - 2004. - 27. - P. 17-20.Koro C.E., Bowlin S.J., Bourgeois N., Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report // Diabetes Care. - 2004. - 27. - P. 17-20.Saydah S.H., Fradkin J., Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes // JAMA. - 2004. - 291. - Р. 335-342.Saydah S.H., Fradkin J., Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes // JAMA. - 2004. - 291. - Р. 335-342.Turner R.C., Cull C.A., Frighi V., Holman R.R. UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: prospective requirement for multiple therapies (UKPDS 49) // JAMA. - 1999. - 281. - Р. 2005-2012.Turner R.C., Cull C.A., Frighi V., Holman R.R. UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: prospective requirement for multiple therapies (UKPDS 49) // JAMA. - 1999. - 281. - Р. 2005-2012.Nathan D.M., Buse J.B., Davidson M.B. et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association of the study of diabetes // Diabetes care. - 2008. - 31. - Р. 1-11.Nathan D.M., Buse J.B., Davidson M.B. et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association of the study of diabetes // Diabetes care. - 2008. - 31. - Р. 1-11.American Diabetes Association. Standards of medical care in diabetes - 2008 // Diabetes care. - 2008. - 31(suppl 1). - S12-S54.American Diabetes Association. Standards of medical care in diabetes - 2008 // Diabetes care. - 2008. - 31(suppl 1). - S12-S54.Guideline for management of postmeal glucose // International Diabetes Federation. - 2007. - Available at: http://www.idf.org.Guideline for management of postmeal glucose // International Diabetes Federation. - 2007. - Available at: http://www.idf.org.Алгоритмы специализированной помощи больным сахарным диабетом / Под ред. И.И. Дедова, М.В. Шестаковой. - М., 2009.Алгоритмы специализированной помощи больным сахарным диабетом / Под ред. И.И. Дедова, М.В. Шестаковой. - М., 2009.Holman R.R., Paul S.K., Bethel M.A., Mattews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes mellitus // N. Engl. J. Med. - 2008. - 359. - Р. 1577-1589.Holman R.R., Paul S.K., Bethel M.A., Mattews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes mellitus // N. Engl. J. Med. - 2008. - 359. - Р. 1577-1589.Yki-Jarvinen H. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes // Diabetes Care. - 2000. - 23. - Р. 1130-1136.Yki-Jarvinen H. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes // Diabetes Care. - 2000. - 23. - Р. 1130-1136.Riddle M. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients // Diabetes Care. - 2003. - 26. - Р. 3080-3086.Riddle M. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients // Diabetes Care. - 2003. - 26. - Р. 3080-3086.Rosenstock J. Reduced hypoglycemia risk with insulin glargine: a metaanalysis comparing insulin glargine with human NPH in type 2 diabetes // Diabetes Care. - 2005. - 28. - Р. 950-955.Rosenstock J. Reduced hypoglycemia risk with insulin glargine: a metaanalysis comparing insulin glargine with human NPH in type 2 diabetes // Diabetes Care. - 2005. - 28. - Р. 950-955.Plank J. et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of a longacting insulin analog detemir // Diabetes Care. - 2005. - 28. - Р. 1107-1112.Plank J. et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of a longacting insulin analog detemir // Diabetes Care. - 2005. - 28. - Р. 1107-1112.European Public Assessment Report, LEVEMIR, EMEA 2004, http:www.emea.europa.eu/humandocs/Humans/EPAR/levemir/levemir. htm.European Public Assessment Report, LEVEMIR, EMEA 2004, http:www.emea.europa.eu/humandocs/Humans/EPAR/levemir/levemir. htm.Hermansen K., Davies M., Derezinski T. et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes // Diabetes Care. - 2006. - 29. - Р. 1269-1274.Hermansen K., Davies M., Derezinski T. et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes // Diabetes Care. - 2006. - 29. - Р. 1269-1274.Philis-Tsimikas A., Charpentier G., Clauson P. et al. Comparison of oncedaily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes // Clin. Ther. - 2006. - 28. - Р. 1569-1581.Philis-Tsimikas A., Charpentier G., Clauson P. et al. Comparison of oncedaily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes // Clin. Ther. - 2006. - 28. - Р. 1569-1581.Rosenstock J., Davies M., Home P.D. et al. A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucse-lowering drugs in insulin-naпve people with type 2 diabetes // Diabetologia. - 2008. - 51. - Р. 408-416.Rosenstock J., Davies M., Home P.D. et al. A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucse-lowering drugs in insulin-naпve people with type 2 diabetes // Diabetologia. - 2008. - 51. - Р. 408-416.
The authors declare that there are no conflicts of interest present.